FIGURE 6.
Pattern of PSMC1 (A), PSMC2 (B), PSMC3 (C), PSMC4 (D), and PSMC5 (E) overexpressions in relation to LUAD patients’ age, individual cancer stages, and nodal metastasis status represented in box plots. Several significant associations between PSMCs expression levels and LUAD patients’ clinical features were observed. Normal: samples collected from normal tissues adjacent to the cancerous tissues of LUAD patients within TCGA cohorts without any demographic and clinical stratification (Source: The Cancer Genome Atlas). Please correspond to Supplementary Table S1 for a detailed observation of the clinical parameters.